C&R Research is working to address challenges in drug safety management, including classifying safety signals and determining their priority.

C&R Research to Host "Drug Signal Detection" Drug Safety Management Webinar View original image

C&R Research announced on November 3 that it will host its ninth webinar on December 2, titled "Understanding Drug Signal Detection at a Glance: From Concepts to Basic Statistics (PRR)."


The event is designed to strengthen companies' pharmacovigilance (PV) capabilities by examining signal detection systems and how to calculate the proportional reporting ratio (PRR), a statistical measure. C&R Research plans to offer insights into drug safety management by addressing errors in statistical interpretation and outlining the scientific basis for regulatory responses.


The webinar will feature two sessions. First, Lee Hyunah, head of C&R Research's PV team, will walk through the process of identifying meaningful signals in adverse event data, using case studies.


Next, Dr. Jung Jiwon, a BS advisor at C&R Research, will explain how the PRR is calculated and how it differs from an incidence rate. The session will also introduce basic principles for interpreting indicators to prevent over- or underinterpretation of data.


C&R Research's speakers said, "This is an opportunity to understand the full process, from clarifying the concept of signal detection to filtering signals. We expect it to be highly beneficial to professionals in the field by sharing perspectives on the proper interpretation of statistical indicators."



Anyone can register for free on the C&R Research website. Advance registration is open through November 27.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing